3345 studies found for:    Japan
Show Display Options
Rank Status Study
1 Unknown  Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Capecitabine;   Drug: S-1
2 Completed Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: lenalidomide;   Drug: dexamethasone
3 Completed
Has Results
Adalimumab in Adult Japanese Subjects With Psoriasis
Condition: Psoriasis
Intervention: Biological: adalimumab
4 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
5 Completed
Has Results
Study to Investigate the Efficacy of Symbicort® SMART.
Condition: Asthma
Interventions: Drug: Symbicort Turbuhaler;   Drug: Terbutaline Turbuhaler
6 Completed A Study of MEDI-575 in Patients With Advanced Solid Malignancies
Condition: Advanced Solid Malignancies
Intervention: Drug: MEDI-575
7 Completed Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)
Condition: Allergic Asthma
Intervention: Drug: omalizumab
8 Active, not recruiting A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non Small Cell Lung
Interventions: Drug: Pemetrexed;   Drug: Gefitinib
9 Active, not recruiting Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
Conditions: Gastric Ulcer;   Duodenal Ulcer
10 Active, not recruiting Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
Condition: COPD
Interventions: Drug: Lysozyme hydrochloride;   Drug: Placebo
11 Completed Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
Condition: Nocturia
Interventions: Drug: A. Desmopressin 10 microgram;   Drug: B: Desmopressin 25 microgram;   Drug: C: Placebo
12 Recruiting Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol 50/250mcg;   Drug: fluticasone propionate/salmeterol placebo;   Drug: tiotropium bromide 18mcg;   Drug: tiotropium bromide placebo;   Drug: fluticasone propionate/salmeterol 50/250mcg and tiotropium 18mcg
13 Recruiting Safety and Efficacy of Extended Treatment With Secukinumab in Anti-TNF Inadequate Responders in RA.
Condition: Rheumatoid Arthritis
Intervention: Biological: Secukinumab (AIN457)
14 Completed A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
Conditions: Gastric Cancer;   Neoplasm Metastasis
Interventions: Drug: 5-FU continuous infusion;   Drug: MTX + 5-FU sequential therapy
15 Completed An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Condition: Myasthenia Gravis
Intervention: Drug: tacrolimus
16 Completed PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
17 Completed
Has Results
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
Condition: Neuralgia, Postherpetic
Interventions: Drug: Placebo;   Drug: Pregabalin
18 Completed
Has Results
Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients
Condition: Early Parkinson Disease (Early PD)
Interventions: Drug: Pramipexol Extended Release;   Drug: Pramipexol Immediate Release;   Drug: Placebo
19 Completed A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.
Conditions: Primary Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: PF-03187207;   Drug: Latanoprost 0.005%;   Drug: PF-03187207 Vehicle;   Drug: Latanoprost Vehicle
20 Completed
Has Results
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa
Condition: Parkinson Disease

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years